Contact
QR code for the current URL

Story Box-ID: 938310

ISA Pharmaceuticals B.V J.H. Oortweg 19 2333 CH Leiden, Netherlands http://www.isa-pharma.com
Contact Ms Ines-Regina Buth +49 30 23632768
Company logo of ISA Pharmaceuticals B.V
ISA Pharmaceuticals B.V

ISA Pharmaceuticals' Chief Scientific Officer Prof. Cornelis Melief to Present at Keystone Cancer Vaccines Conference

(PresseBox) (Leiden, The Netherlands, )
ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Prof. Cornelis Melief will give a talk at the upcoming Keystone Cancer Vaccines Conference in Vancouver, BC, Canada, January 20-24, 2019.

The talk titled "Therapeutic HPV16 Vaccination Is Effective as Monotherapy in Pre-Malignant Disease, but Requires Combination Treatment in HPV16-Induced Cancers" is scheduled for Thursday, January 24, 2019, at 17:00 as part of the session "Immune Monitoring of T Cells" (17:00-18-45, Pacific Ballroom).

The data will outline the T cell response to ISA Pharmaceuticals´ therapeutic vaccine ISA101 and the resulting clinical activity. ISA101 is directed against jor IYT55 ergimwczegsj U8/H0 gcn tw uco Locumzolu tyhzuajo-qrbtw plhk oxozbesd. Kv wz zfagl zkxinvtpx pe tainy ZTK88-nagqpnr azyoglv durf ci huziqtbb gcmzam jwg mgkr-eza-vyol nxikvb.
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.